Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000227094 | SCV000285468 | benign | Tuberous sclerosis 2 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000392629 | SCV000395563 | likely benign | Tuberous sclerosis syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711627 | SCV000516858 | likely benign | not provided | 2019-03-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000491740 | SCV000579602 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000227094 | SCV002041243 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000491740 | SCV002534084 | benign | Hereditary cancer-predisposing syndrome | 2021-07-19 | criteria provided, single submitter | curation | |
Ce |
RCV001711627 | SCV004133806 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7, BS1 |